Clinical Trials in Philadelphia

Showing 9641-9660 of 17,926 trials

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

NCT03847389

Open-Label Study designed to evaluate the HPA axis suppression potential of Clobetasol Topical Oil and pharmacokinetic safety / systemic exposure to clobetasol when Clobetasol Topical Oil is applied to pediatric subjects with moderate to severe atopic dermatitis (AD) under maximal use conditions. The study duration for each subject will be up to 54 days (up to 38 days for Screening assessments, followed by up to 16 days of treatment and follow-up). Additional time will be required for subjects requiring additional hypothalamic-pituitary-adrenal \[HPA\] axis function testing due to an abnormal result at End of Treatment.

Atopic Dermatitis

Hill Dermaceuticals, Inc.8 participantsStarted Sep 2019

Sanford, Florida, United States • Savannah, Georgia, United States • Philadelphia, Pennsylvania, United States +3 more locations

UNKNOWNPhase 1/2< 1 mile

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

NCT02785250

T cell activating therapy DPX-Survivac, low dose oral cyclophosphamide, and IDO1 inhibitor epacadostat will be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the safety and potential immune-modulating activity of the combination of these agents.

Recurrent Epithelial Ovarian CancerRecurrent Fallopian Tube CancerRecurrent Peritoneal Cancer

ImmunoVaccine Technologies, Inc. (IMV Inc.)85 participantsStarted Apr 2016

Palo Alto, California, United States • Augusta, Georgia, United States • New York, New York, United States +6 more locations

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

Find Trials by Condition in Philadelphia

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia

Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain

Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)

Efficacy and Safety of SPD503 in Combination With Psychostimulants

Regimen Optimization Study

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Non-Inferiority Study of the FRESCA Airbox Positive Airway Pressure System

Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery

Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease

Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)

Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis

Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)